NantKwest, Inc. Uncategorized Contracts & Agreements
29 Contracts & Agreements
- Description of Registrants Securities (Filed With SEC on March 19, 2024)
- Letter of Amendment dated (Filed With SEC on November 9, 2023)
- Letter of Amendment dated (Filed With SEC on November 9, 2023)
- Letter of Amendment dated (Filed With SEC on November 9, 2023)
- Letter of Amendment dated (Filed With SEC on November 9, 2023)
- Letter of Amendment dated (Filed With SEC on November 9, 2023)
- Offer Letter, dated October 12, 2021, by and among ImmunityBio, Inc. and Regan Lauer (Filed With SEC on March 1, 2022)
- Description of Registrants Securities (Filed With SEC on March 1, 2022)
- Open Market Sale Agreement dated April 30, 2021, by and between ImmunityBio, Inc. and Jefferies LLC (Filed With SEC on May 3, 2021)
- Offer Letter, dated August 3, 2020, by and among ImmunityBio, Inc. and David Sachs (Filed With SEC on January 19, 2021)
- Letter Agreement, dated February 14, 2018, by and between NantPharma, LLC and Immunotherapy NANTibody, LLC (Filed With SEC on January 19, 2021)
- FDA Milestone Contingent Value Rights Agreement, dated July 31, 2017, by and between ImmunityBio, Inc. and the Stockholder Representative thereunder (Filed With SEC on January 19, 2021)
- Offer Letter between the Company and Richard Adcock, dated October 26, 2020 (Filed With SEC on November 9, 2020)
- First Amendment to the July 1, 2019 Letter Agreement between the Company and Immuno-Oncology Clinic, Inc., dated March 31, 2020 (Filed With SEC on May 11, 2020)
- Cost Allocation Agreement between the Company and ImmunityBio, Inc. and its subsidiaries, dated January 29, 2020 (Filed With SEC on March 25, 2020)
- Description of the Registrants Securities (Filed With SEC on March 25, 2020)
- Letter Agreement between the Company and Immuno-Oncology Clinic, Inc., dated July 5, 2019 (Filed With SEC on August 6, 2019)
- Letter Agreement with Barry Simon dated May 3, 2018 (Filed With SEC on August 6, 2018)
- NantKwest Inc. | 9920 Jefferson Blvd, Culver City, CA 90232 www.nantkwest.com (Filed With SEC on May 16, 2016)
- 3530 John Hopkins Court, San Diego, CA 92121 Main: (858) 633-0300 Fax: (858) 380-1999 www.NantKwest.com (Filed With SEC on March 30, 2016)
- LICENSEAGREEMENT BETWEEN ZELLERX CORPORATION AND HANS G. KLINGEMANN (Filed With SEC on July 27, 2015)
- LICENSEAGREEMENT BETWEEN ZELLERX CORPORATION AND HANS G. KLINGEMANN (Filed With SEC on July 27, 2015)
- LICENSEAGREEMENT BETWEEN ZELLERX CORPORATION AND FOX CHASE CANCER CENTER (Filed With SEC on July 27, 2015)
- LICENSEAGREEMENT BETWEEN ZELLERX CORPORATION AND HANS G. KLINGEMANN (Filed With SEC on June 19, 2015)
- LICENSEAGREEMENT BETWEEN ZELLERX CORPORATION AND FOX CHASE CANCER CENTER (Filed With SEC on June 19, 2015)
- AGREEMENT (Filed With SEC on June 19, 2015)
- AGREEMENT (Filed With SEC on June 19, 2015)
- CONKWEST, INC. 2014 EQUITYINCENTIVE PLAN (Filed With SEC on June 19, 2015)
- CONKWEST, INC. 2533 SouthCoast Highway 101, Suite 210 Cardiff by the Sea, CA 92007 June 18, 2015 (Filed With SEC on June 19, 2015)
